510(k) Report

FDA applicant

Immuno-Mycologics, Inc.

Mchenry, IL26 decisions1979–20125 recalls

FDA records 26 decisions for Immuno-Mycologics, Inc. (Mchenry, IL) from 1979 to 2012: 26 510(k) clearances. Most are in product codes GMD (Antisera, Latex Agglutination, Cryptococcus…) and GMJ (Antigens, Histoplasma Capsulatum, All). Its devices cite 4 predicates, 2 of them its own earlier devices. 5 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, microbiology panel, where it files most

How often FDA has decided Immuno-Mycologics, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

2in 2012

2011: 22012: 2
2007high 2 (2011) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2022

2016: 22018: 12019: 12022: 1
2007high 2 (2016) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Immuno-Mycologics, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Immuno-Mycologics, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Immuno-Mycologics”

FDA records each applicant name separately; these may or may not be the same firm.